Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
36.35
-0.08 (-0.22%)
At close: Nov 7, 2025, 4:00 PM EST
36.28
-0.07 (-0.19%)
After-hours: Nov 7, 2025, 4:14 PM EST

Dianthus Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21
1,556645154--
Market Cap Growth
96.62%318.69%---
Enterprise Value
1,001364-35--
Last Close Price
36.2821.8010.40--
PS Ratio
505.37103.4854.53--
PB Ratio
2.851.830.91--
P/TBV Ratio
2.851.830.91--
EV/Sales Ratio
325.3258.45---
Debt / Equity Ratio
0.000.000.000.01-
Asset Turnover
0.010.020.020.14-
Quick Ratio
17.0914.9618.099.861.70
Current Ratio
17.3515.2218.439.971.75
Return on Equity (ROE)
-28.57%-32.60%-35.92%-73.25%-
Return on Assets (ROA)
-18.82%-23.01%-22.94%-40.12%-
Return on Capital (ROIC)
-19.80%-24.33%-24.69%-47.27%-
Earnings Yield
-8.12%-13.17%-28.26%--
FCF Yield
-7.05%-12.13%-23.99%--
Buyback Yield / Dilution
-28.44%-546.44%-489.48%78.17%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q